Merck : Phase 3 Trial On Metastatic Triple-Negative Breast Cancer Meets Primary Endpoint

Merck & Co., Inc. (MRK) said that a phase 3 KEYNOTE-355 trial met primary endpoint of overall survival in patients with metastatic triple-negative breast cancer or mTNBC whose tumors expressed PD-L1.

Findings from the final analysis showed first-line treatment with KEYTRUDA in combination with chemotherapy demonstrated a statistically significant and clinically meaningful improvement in overall Survival compared with chemotherapy alone in patients with mTNBC whose tumors expressed PD-L1 (Combined Positive Score [CPS] =10). No new safety signals were identified.

These Overall Survival results follow a previous interim analysis that showed KEYTRUDA in combination with chemotherapy significantly improved PFS compared with chemotherapy alone in these patients.

In the U.S., KEYTRUDA is currently approved in combination with chemotherapy for the treatment of patients with locally recurrent unresectable or metastatic TNBC whose tumors express PD-L1 as determined by an FDA-approved test.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Twitter has rolled out the tipping feature called "Tips" for everyone around the globe using the microblogging site with more payment options to choose from, including cryptocurrencies such as Bitcoin. This is a new way for people to receive and show support on Twitter with money. The feature is currently available on iOS and will be available on Android over the coming weeks. Amazon.com has launched weekly Max-Your-Vax Sweepstakes to encourage their employees to get vaccinated against COVID-19. The sweepstakes began on August 6, 2021 and ends on October 21, 2021, with six draws during the sweepstakes period for 18 prizes worth nearly $2 million, including cash prizes, new vehicle or cash and vacation plus 40 hours of Paid Time Off. Target Corp. announced its plans to hire 100,000 seasonal team members at its stores across the country for this holiday shopping season, though fewer than previous years. With this, the company aims to invest in more flexible scheduling, training, pay and benefits for its existing team members. In a statement, the company said it is also offering around 5 million more hours to its existing staff.
Follow RTT